Similar Articles
1161 Current management of hepatocellular carcinoma: An Eastern perspective
1162 Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
1163 Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma
1164 Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma
1165 Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma
1166 Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma
1167 Lymphoepithelioma-like cholangiocarcinoma: A mimic of hepatocellular carcinoma on imaging features
1168 Management of hepatocellular carcinoma with portal vein thrombosis
1169 Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: Incidence and risk factors
1170 Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA